Perspectives of Induction With Chemo and/or Immune Check Point Inhibition in Head and Neck Organ Preservation Treatment

by Susanne Wiegand, Gunnar Wichmann, Andreas Dietz
Published 2019-03-01

Laryngeal Preservation Approaches: Considerations for New Selection Criteria Based on the DeLOS-II Trial

by Andreas Dietz, Susanne Wiegand, Thomas Kuhnt, Gunnar Wichmann
Published 2019-07-01

Development of a Human Leukocyte Antigen Score to Predict Progression-Free Survival in Head and Neck Squamous Cell Carcinoma Patients

by Gunnar Wichmann, Gunnar Wichmann, Claudia Lehmann, Cindy Herchenhahn, Cindy Herchenhahn, Marlen Kolb, Mathias Hofer, Susanne Wiegand, Andreas Dietz, Andreas Dietz
Published 2018-05-01

Reduced Cytokine Release in Ex Vivo Response to Cilengitide and Cetuximab Is a Marker for Improved Survival of Head and Neck Cancer Patients

by Susan Cedra, Susanne Wiegand, Marlen Kolb, Andreas Dietz, Gunnar Wichmann
Published 2017-09-01

Choosing the Right Treatment Option for the Right R/M HNSCC Patient: Should We Adhere to PFE for First-Line Therapy?

by Katharina Lübbers, Mykola Pavlychenko, Theresa Wald, Susanne Wiegand, Andreas Dietz, Veit Zebralla, Gunnar Wichmann
Published 2021-07-01

Verification and characterization of an alternative low density lipoprotein receptor-related protein 1 splice variant.

by Marlen Kolb, Susanne Kurz, Angelika Schäfer, Klaus Huse, Andreas Dietz, Gunnar Wichmann, Gerd Birkenmeier
Published 2017-01-01

Course of Self-Reported Dysphagia, Voice Impairment and Pain in Head and Neck Cancer Survivors

by Veit Zebralla, Susanne Wiegand, Andreas Dietz, Gunnar Wichmann, Thomas Neumuth, Anja Mehnert-Theuerkauf, Andreas Hinz
Published 2021-02-01

Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC)

by Julia Siemert, Theresa Wald, Marlen Kolb, Isolde Pettinella, Ulrike Böhm, Markus Pirlich, Susanne Wiegand, Andreas Dietz, Gunnar Wichmann
Published 2021-07-01

Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve...

by Gunnar Wichmann, Maria Willner, Thomas Kuhnt, Regine Kluge, Tanja Gradistanac, Theresa Wald, Sandra Fest, Florian Lordick, Andreas Dietz, Susanne Wiegand, Veit Zebralla
Published 2021-05-01

Ethyl Pyruvate Combats Human Leukemia Cells but Spares Normal Blood Cells.

by Gerd Birkenmeier, Nasr Y A Hemdan, Susanne Kurz, Marina Bigl, Philipp Pieroh, Tewodros Debebe, Martin Buchold, Rene Thieme, Gunnar Wichmann, Faramarz Dehghani
Published 2016-01-01

Obtaining Patient-Reported Outcomes Electronically With “OncoFunction” in Head and Neck Cancer Patients During Aftercare

by Veit Zebralla, Juliane Müller, Theresa Wald, Andreas Boehm, Gunnar Wichmann, Thomas Berger, Klemens Birnbaum, Katharina Heuermann, Steffen Oeltze-Jafra, Thomas Neumuth, Susanne Singer, Matthias Büttner, Andreas Dietz, Susanne Wiegand
Published 2020-11-01

Discrimination of Head and Neck Squamous Cell Carcinoma Patients and Healthy Adults by 10-Color Flow Cytometry: Development of a Score Based on Leukocyte Subsets

by Gunnar Wichmann, Clara Gaede, Susanne Melzer, Jozsef Bocsi, Sylvia Henger, Christoph Engel, Kerstin Wirkner, John Ross Wenning, Theresa Wald, Josefine Freitag, Maria Willner, Marlen Kolb, Susanne Wiegand, Markus Löffler, Andreas Dietz, Attila Tárnok
Published 2019-06-01